Skip to main content
Explore URMC
menu

Scott A. Gerber, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-1488

Office: (585) 276-7380

Research Labs

Faculty Appointments

Biography

Research

Dr. Gerber is a tumor immunologist whose laboratory focuses on harnessing the immune system to recognize and kill cancerous cells. His lab uses an immunotherapeutic approach to enhance the efficacy of chemo/radiotherapies to control or even cure both primary and metastatic malignancies.

Credentials

Education

1997
BS | SUNY Coll at Fredonia
Biology

2001
MS | University of Rochester School of Medicine & Dentistry
Immunology

2005
PhD | University of Rochester School of Medicine & Dentistry
Microbiology & Immunology

Post-doctoral Training & Residency

2005 - 2008
Yale University, New Haven, CT (Mentor: Jordan Pober)

Awards

2019
National Cancer Institute R01 CA230277

2019
URMC Outstanding Graduate Student Teacher Award

2018 - 2019
University Research Award

2018
Clinical and Translational Science Institute Pilot Study Award

2017
Wilmot Cancer Institute Collaborative Award

2016
Washington University SPORE in Pancreatic Cancer Developmental Research Award

2016
UR/UB Genomics Collaborative Pilot Award

2012 - 2013
American Association of Immunologist (AAI) Early Career Faculty Travel Grant

2008
Anna Fuller Fund Fellowship in Molecular Oncology
Sponsor: Yale University
Location: New Haven, CT

2006
Vincent du Vigneaud Award for outstanding doctoral thesis
Sponsor: University of Rochester Medical Center
Location: Rochester, NY

VIEW ALL expand_more

Publications

Journal Articles

4/11/2022
Khazan N, Kim KK, Hansen JN, Singh NA, Moore T, Snyder CWA, Pandita R, Strawderman M, Fujihara M, Takamura Y, Jian Y, Battaglia N, Yano N, Teramoto Y, Arnold LA, Hopson R, Kishor K, Nayak S, Ojha D, Sharon A, Ashton JM, Wang J, Milano MT, Miyamoto H, Linehan DC, Gerber SA, Kawar N, Singh AP, Tabdanov ED, Dokholyan NV, Kakuta H, Jurutka PW, Schor NF, Rowswell-Turner RB, Singh RK, Moore RG. "Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors ." Journal of medicinal chemistry.. 2022 Apr 11; Epub 2022 Apr 11.

3/8/2022
Ortiz-Bonilla CJ, Uccello TP, Gerber SA, Lord EM, Messing EM, Lee YF. "Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity." International journal of molecular sciences.. 2022 Mar 8; 23(6)Epub 2022 Mar 08.

2022
Uccello TP, Kintzel SA, Mills BN, Murphy JD, Garrett-Larsen J, Battaglia NG, Rodriguez CJ, Drage MG, Ye J, Love TMT, Johnston CJ, Repasky EA, Qiu H, Linehan DC, Lord EM, Gerber SA. "Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy." Advances in radiation oncology.. 2022 7(2):100867. Epub 2021 Dec 09.

VIEW ALL PUBLICATIONS